Product
PRAX-222
Aliases
PRAX-222 - Fixed Doses, PRAX-222 - Initial Ascending Doses, PRAX-222 - Initial Dose, PRAX-222 - Optional Ascending Doses
1 clinical trial
2 indications
Indication
SCN2A-DEEIndication
EpilepsyClinical trial
A Seamless, Clinical Trial to Investigate the Safety and Efficacy of Multiple Doses of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathyStatus: Active (not recruiting), Estimated PCD: 2025-07-01